April 16, 2019
In a letter released April 10, the CDC clarified its federal opioid prescribing guidelines were not meant to be unduly restrictive for chronic pain patients. The clarification came in response to repeated concerns that the rules were preventing patients from getting the pain care they needed.
“The Guideline is not intended to deny any patients who suffer with chronic pain from opioid therapy as an option for pain management,” wrote Deborah Dowell, MD, MPH, chief medical officer of the CDC. “Rather, the Guideline is intended to ensure that clinicians and patients consider all safe and effective treatment options for patients.”